Gross booking revenue in Q3 FY25 was ₹2,148.9 crore, indicating demand in the travel sector remained strong.
One of the major highlights in this quarter was a significant decline in gross debt, which reduced by 28% against the previous quarter.
Company’s operating EBITDA tumbled as much as 44.40% to ₹26.10 Crore against ₹47 Crore in the previous corresponding quarter.
EBITDA was up 14.8% and stood at ₹635 crore compared to ₹553.2 crore, indicating improved operational performance.
EBITDA surged to ₹600.3 crore, up from a loss of ₹208.7 crore in the year-ago quarter, indicating better operational efficiency
Srini Pallia, CEO, and MD of Wipro stated that the company is delighted to welcome Amit Kumar to its leadership team.
The 34.5% year on year increase in revenue to ₹390 crore from Indian operations was the main contributor to revenue growth.
The US market is a key growth driver for the company, accounting for almost 47% of Zydus Lifesciences' revenue.
Here are some of the stocks that may see significant price movement today.
Net Interest Income (NII) slightly reduced by 0.5% to ₹480 crore as against ₹482 crore in Q3 FY24

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.